Nuclease-Cleavage Diagnostic Device for Point-Mutation Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing diagnostic technologies, such as PCR and CRISPR-based methods, face challenges in detecting small genetic variations and require laboratory equipment, lacking specificity and sufficient signal amplification.

Innovation Solution

A diagnostic device with reaction chambers, a membrane, and a detector for detecting a target nucleic acid molecule, utilizing a nuclease to cleave nucleic acid molecules bonded to markers, allowing for signal amplification and separation of cleaved portions through a porous membrane or magnetic beads.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If PCR amplification is used on a LOC, then amplification of nucleic acid sequences is achieved, but specificity to detect small changes such as point mutations is insufficient

Engineering Contradiction:
Improvenumber of amplified sequencesVSAvoidspecificity for point mutations
Core Design Contradiction:
Quantity of substanceVSMeasurement precision

Solution Approach 1:

The detection system is segmented into multiple functional chambers (reaction chamber, separation chamber, detection chamber) that perform distinct operations. The nuclease cleavage step is separated from amplification, allowing each process to be optimized independently for both quantity generation and specificity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

A bulky molecule acts as an intermediary carrier that temporarily binds the target nucleic acid during cleavage, then is separated away to allow detection of the cleaved fragments. This intermediary enables the cleavage reaction to occur with high specificity while allowing subsequent detection of the cleaved products.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Quantity of substance

If the number of amplified sequences is increased to produce a detectable signal, then signal amplification is achieved, but the methods require laboratory equipment and facilities

Engineering Contradiction:
Improvenumber of amplified sequencesVSAvoidlaboratory equipment requirements
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

Multiple functions (amplification, cleavage, separation, detection) are merged into a single integrated LOC device with microfluidic channels connecting compact chambers. This consolidation eliminates the need for separate laboratory equipment while maintaining all necessary functions for signal amplification and detection.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

A porous membrane is used in the separation chamber to physically separate the bulky molecule from the cleaved nucleic acid fragments based on size differences. This simple porous barrier enables separation without requiring complex centrifugation or filtration equipment.

Inventive Principle:
Principle #31Porous materials

3Measurement precision

If a membrane with appropriate porosity is used to filter the first portion from the solution containing the second portion, then separation of cleaved portions is achieved, but device complexity increases

Engineering Contradiction:
Improveseparation of first portion and second portionVSAvoidmembrane filtration system
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The porous membrane performs separation automatically based on the inherent size difference between the bulky molecule and the cleaved nucleic acid fragments. No external control or complex mechanism is needed - the size-based filtration occurs passively as fluid flows through the membrane, making the system self-regulating.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables rapid, accurate, and cost-effective on-site detection of nucleic acid molecules without laboratory equipment, allowing for simultaneous detection of multiple pathogens or genetic variants from a single sample.

Implementation Method 1

a membrane in liquid connection to the at least one reaction chamber, having porosity sized to filter the first portion from the solution containing the second portion

Methodology Applied
Scientific EffectPorosity-based filtration: Porosity

Implementation Method 2

at least one reaction chamber, comprising a nuclease for cleaving a nucleic acid molecule

Methodology Applied
Scientific EffectEnzymatic cleavage: Enzyme

Data Source

PatentUS12435357B2Diagnostic device for detecting a target nucleic acid molecule in a biological sample
Publication Date: 2025.10.07 KANSO DIAGNOSTICS LTD
  • US12435357B2 patent drawing
  • US12435357B2 patent drawing
  • US12435357B2 patent drawing

AI summary

Diagnostic devices comprising: an inlet for receiving a solution comprising a biological sample comprising a target nucleic acid molecule; at least one reaction chamber, comprising a nuclease for cleaving a nucleic acid molecule, into a first portion bonded to a marker and a second portion bonded to a bulky molecule; a membrane in liquid connection to the at least one reaction chamber, having porosity sized to filter the first portion from the solution containing the second portion; and an informative chamber configured to receive the filtered first portion, having at least one of, a transparent region showing a visible marker; and a detector for detecting the marker are provided. Methods of using the devices to detect a target nucleic acid molecule in a sample are also provided.